Larsen S K, Solomon H F, Caldwell G, Abrams M J
Johnson Matthey Pharmaceutical, West Chester, Pennsylvania 19380, USA.
Bioconjug Chem. 1995 Sep-Oct;6(5):635-8. doi: 10.1021/bc00035a020.
The stannous reduction of [99mTc]pertechnetate in the presence of tricine results in the formation of the new labeling precursor complex [[99m-Tc]tricine. This complex has improved efficacy for the 99mTc labeling of hydrazinonicotinate-modified IgG compared to [99mTc]glucoheptonate. FAB mass spectral analysis of the product formed by the reaction of TcOCl4 with tricine indicates the formation of TcO(tricine x 2H)2.